ETrade Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

ETrade Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-103,875	Closed	-$1.86M	–	799
2017 Q4	$1.86M	Sell	103,875 -1,133	-1%	-$13.9K	0.06%	188
2017 Q3	$1.24M	Buy	105,008 +46,421	+79%	+$521K	0.04%	274
2017 Q2	$615K	Buy	58,587 +4,036	+7%	+$41.1K	0.02%	414
2017 Q1	$600K	Buy	54,551 +3,445	+7%	+$40K	0.02%	399
2016 Q4	$692K	Buy	+51,106	New	+$713K	0.03%	342

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

ETrade Capital Management's SCMP Position: Q1 2018 in Review

ETrade Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 103,875 shares — an estimated $1.86M sold.

ETrade Capital Management first reported a position in SCMP in Q4 2016 and held it in 5 quarters. The position peaked at $1.86M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

ETrade Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
ETrade Capital Management sold 103,875 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.86M.
ETrade Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2016 and held it in 5 quarters.
ETrade Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $1.86M in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on ETrade Capital Management's 13F filing for Q1 2018, filed 7 May 2018.